LGVAX vs. AVERX
Compare and contrast key facts about ClearBridge Value Fund Class A (LGVAX) and Ave Maria Value Focused Fund (AVERX).
LGVAX is an actively managed fund by ClearBridge. It was launched on Feb 2, 2009. AVERX is a passively managed fund by Schwartz Investment Counsel that tracks the performance of the S&P 500® Index. It was launched on Jan 1, 1984.
Performance
LGVAX vs. AVERX - Performance Comparison
Loading graphics...
LGVAX vs. AVERX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
LGVAX ClearBridge Value Fund Class A | 1.17% | 17.32% |
AVERX Ave Maria Value Focused Fund | 19.97% | 0.37% |
Returns By Period
In the year-to-date period, LGVAX achieves a 1.17% return, which is significantly lower than AVERX's 19.97% return.
LGVAX
- 1D
- 2.38%
- 1M
- -5.38%
- YTD
- 1.17%
- 6M
- 4.09%
- 1Y
- 12.86%
- 3Y*
- 14.66%
- 5Y*
- 9.20%
- 10Y*
- 11.44%
AVERX
- 1D
- 1.67%
- 1M
- -6.66%
- YTD
- 19.97%
- 6M
- 18.80%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
LGVAX vs. AVERX - Expense Ratio Comparison
LGVAX has a 1.01% expense ratio, which is lower than AVERX's 1.26% expense ratio.
Return for Risk
LGVAX vs. AVERX — Risk / Return Rank
LGVAX
AVERX
LGVAX vs. AVERX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ClearBridge Value Fund Class A (LGVAX) and Ave Maria Value Focused Fund (AVERX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LGVAX | AVERX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.74 | — | — |
Sortino ratioReturn per unit of downside risk | 1.11 | — | — |
Omega ratioGain probability vs. loss probability | 1.17 | — | — |
Calmar ratioReturn relative to maximum drawdown | 1.03 | — | — |
Martin ratioReturn relative to average drawdown | 4.31 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| LGVAX | AVERX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.74 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.52 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.60 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.66 | 1.17 | -0.52 |
Correlation
The correlation between LGVAX and AVERX is 0.63, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
LGVAX vs. AVERX - Dividend Comparison
LGVAX's dividend yield for the trailing twelve months is around 10.64%, more than AVERX's 0.34% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LGVAX ClearBridge Value Fund Class A | 10.64% | 10.76% | 10.83% | 12.64% | 8.49% | 18.44% | 6.01% | 0.54% | 1.86% | 0.50% | 0.93% | 0.39% |
AVERX Ave Maria Value Focused Fund | 0.34% | 0.41% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
LGVAX vs. AVERX - Drawdown Comparison
The maximum LGVAX drawdown since its inception was -40.40%, which is greater than AVERX's maximum drawdown of -11.33%. Use the drawdown chart below to compare losses from any high point for LGVAX and AVERX.
Loading graphics...
Drawdown Indicators
| LGVAX | AVERX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.40% | -11.33% | -29.07% |
Max Drawdown (1Y)Largest decline over 1 year | -12.98% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -20.41% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -40.40% | — | — |
Current DrawdownCurrent decline from peak | -5.61% | -6.66% | +1.05% |
Average DrawdownAverage peak-to-trough decline | -5.25% | -5.39% | +0.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.11% | — | — |
Volatility
LGVAX vs. AVERX - Volatility Comparison
Loading graphics...
Volatility by Period
| LGVAX | AVERX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.03% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 9.48% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 17.29% | 19.13% | -1.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.79% | 19.13% | -1.34% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.26% | 19.13% | +0.13% |